ABIOMED, Inc. (NASDAQ:ABMD)

SamsaricSufferer (< 20) Submitted: 2/27/2013 9:12:30 AM : Start Price: $15.57 ABMD Score: +30.88

Recent FDA investigation resolved without penalties. Continuing growth in device sales. Nothing has changed fundamentally since it was beaten down 30% by the now resolved FDA inquiry.

kkconway (99.29) Submitted: 1/29/2013 2:31:39 PM : Start Price: $13.79 ABMD Score: +49.63

Morningstar pick for top ten 2013 takeover targets

eldomador1 (< 20) Submitted: 3/8/2012 1:55:51 AM : Start Price: $20.93 ABMD Score: -16.07

It saves lives, it cheaper than the alternative, and the company is well run.

HardnoseDotCom (74.78) Submitted: 4/25/2011 1:35:11 PM : Start Price: $16.31 ABMD Score: +11.05

low PEG, strong price uptrend

pyupie0216 (22.42) Submitted: 8/18/2010 5:53:14 PM : Start Price: $9.71 ABMD Score: -75.01

screener

Displacement (< 20) Submitted: 9/16/2009 10:40:13 PM : Start Price: $8.94 ABMD Score: +90.88

I really like these technicals and if it gets some volume and starts breaking its resistance around $9 I can see it going to 11 or 12. We'll see, it's a maybe.

ScreenerStizBear (27.61) Submitted: 6/26/2008 2:26:22 PM : Start Price: $18.47 ABMD Score: +13.20

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

dlee210 (< 20) Submitted: 6/24/2008 5:41:09 PM : Start Price: $18.01 ABMD Score: -7.45

Has the first total transplantable artificial heart. This company has the innovation to create more medical products that will soon be approved and used.

Sqwii (< 20) Submitted: 6/16/2008 10:56:05 AM : Start Price: $18.98 ABMD Score: -9.82

short term pick, equity nr. 2 list

LetterA (66.49) Submitted: 4/6/2008 3:01:41 AM : Start Price: $13.50 ABMD Score: +38.51

Testing a portfolio of companies that start with the letter "A".

samlove (52.81) Submitted: 1/2/2008 1:52:55 PM : Start Price: $15.46 ABMD Score: +23.09

On a strictly technical basis, my magic charts say this will outperform the S&P